Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

JUL 03, 2015 - Yahoo! News

A Must Read - Share

Exclusive: Hospira wins French biosimilar drug tender at 45 percent discount

By Matthias Blamont PARIS (Reuters) - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis, Crohn's disease and psoriasis in a victory for a new type of medicine known as biosimilars.    In a document seen by Reuters, the central purchasing agency for the Assistance Publique - Hôpitaux ...

Tags: Exclusive: Hospira wins French biosimilar drug tender at 45 percent discount,  Pfizer Latest News

JUN 26, 2015 - Huffington Post

A Must Read - Share

Africa Could Be Polio-Free Soon

After years of frustrating pushback, Africa may soon be able to declare itself polio-free. The disease that affects mostly children under 5 and can lead to irreversible paralysis, has been all but wiped out in Africa -- except for in Nigeria. There, religious leaders often interfered with vaccination campaigns, but thanks to increased efforts, the country hasn’t seen a new ...

Tags: Africa Could Be Polio-Free Soon,  Pfizer Latest News

JUN 25, 2015 - Yahoo! News

A Must Read - Share

Canada's Valeant approaches to buy Zoetis: WSJ

(Reuters) - Canada-based drugmaker Valeant Pharmaceuticals International Inc has approached to buy Zoetis Inc , an animal-health company, the Wall Street Journal reported. Shares of Zoetis, whose pipeline includes medicines and vaccines for pets and livestock, were up 2 percent at $56.65 in extended trading. The company, spun off from Pfizer Inc in 2013, was valued at $24.85 billion as ...

Tags: Canada's Valeant approaches to buy Zoetis: WSJ,  Pfizer Latest News

JUN 24, 2015 - Reuters

A Must Read - Share

U.S. CDC updates recommendation for new meningitis B vaccines

(Reuters) - The U.S. Centers for Disease Control and Prevention on Wednesday recommended that decisions to use new meningitis B vaccines from Pfizer and GlaxoSmithKline in people aged 16 to 23 be made on an individual patient basis by physicians, the companies said, potentially paving the way for wider access to the drugs.

Tags: U.S. CDC updates recommendation for new meningitis B vaccines,  Pfizer Latest News

JUN 22, 2015 - Washington Times

A Must Read - Share

Pfizer buying 2 meningitis vaccines from Glaxo for $130M

NEW YORK (AP) - Pfizer will buy two meningitis vaccines from GlaxoSmithKline in a deal that the U.S. drugmaker valued at about $130 million. GlaxoSmithKline PLC was required to sell the vaccines, called Nimenrix and Mencevax, as part of a larger deal where it bought the vaccine business of Swiss ...

Tags: Pfizer buying 2 meningitis vaccines from Glaxo for $130M,  Pfizer Latest News